HairClone – Another One

I almost couldn’t believe my eyes when I started browsing the website for HairClone, a new hair regeneration startup based out of Manchester, UK. Just like that another hair growth technology company has sprung up seemingly out of nowhere, and they have a very interesting plan to make hair regeneration a reality.

Image result for hairclone

Read More

RiverTown Therapeutics Inc. Results: Exclusive

 

https://i1.wp.com/static1.squarespace.com/static/575085041d07c0db05029019/t/575300488a65e246000c510d/1465057400328/rivertown+nontransparent.png?w=760&ssl=1
I’m very happy to be bringing you all an incredible exclusive on Follicle Thought. This week David Weinstein, MD, PhD of RiverTown Therapeutics Inc. reached out to me to share some amazing photo results of his new compound RT1640. Below you will find photographs of a 60+ year old woman and a 42 year old man that received the RT1640 treatment. Both of these results came within 4 months of trialing the compound. Very impressive.
Read More

HairCell Interview: Exclusive


HairCell

Follicle Thought recently had the opportunity to interview Howard Leonhardt of Leonhardt Ventures about his interesting new invention aimed at hair regeneration, HairCell. The Chief Medical Officer of Leonhardt Ventures, Dr. Leslie Miller, also provided some input for certain questions in the interview. Dr. Miller is also Director of the USF Heart Institute and has co-authored one of the leading textbooks on Stem Cell Therapy for Cardiac Regenerative Medicine.

The topics covered in this interview include Howard’s extensive background working with stem cells to regenerate organs over 20 years ago, the planned clinical trial pathway to bring HairCell to market, and an in-depth explanation of how this technology actually works in the human body. Read More

Rapunzel Still Growing, Histogen Talk, Ultimate Guide Update: Weekly Thoughts 8/17/16

Hello everyone,

Welcome to another edition of Weekly Thoughts. This week’s news consists of an update on Christiano’s cellular hair growth startup Rapunzel, some interesting tidbits on Histogen, and updates being made to the Ultimate Guide to Hair Regeneration 2016. Bonus news alert: I will also have an exclusive interview with one of the newer hair growth startups coming next week, stay tuned for that one. Before we get right into the news items I’d like to share with you all a website that a reader of this site named Beth has made in her own efforts to support new effective hair growth treatments coming to be. Please visit her site Hair Growth Campaign. Thank you all for your continued support. Read More

Shiseido is Officially Cleared to Start RCH-01 Trial

Time to see what this is all about


Replicel’s hair growth therapy, RCH-01, has officially received approval by Japanese regulatory authorities to be used in a clinical trial that is now launching. We did hear some rumblings recently that Shiseido was putting the final touches on it’s clinical trial to take place at the Tokyo Medical University Hospital and Toho University Ohasi Medical Center. Now it’s official. Have at it Shiseido, and best wishes from Follicle Thought.

Kyocera joins the Tsuji Party, New Futuristic Cap for Hair Growth: Weekly Thoughts 7/16/16

Hello everyone and welcome to a timely edition of Weekly Thoughts.

The news involving Kyocera and Dr. Tsuji in this Weekly Thoughts is perhaps the best development I’ve heard of this year since the original buzz of the Brotzu lotion a few months back. This edition also features a new intriguing company that is developing a device to be worn on a person’s head to emit bioelectric signals to hair follicles. Sounds weird? Perhaps, but it is based on legitimate research. Check it out. Read More

Shiseido Trial Update, Topical Reverses Baldness after Decades: Weekly Thoughts 7/1/16

Hey everybody, welcome to another installment of Weekly Thoughts. This week we get an encouraging update about the logistics of Shiseido’s trial and more information about the RiverTown Therapeutics Inc. compound.

Shiseido Closer to Trial

News was finally released this week about Shiseido’s upcoming trial in Japan using Replicel’s RCH-01 technology. Shiseido acquired an exclusive license in 2013 to bring Replicel’s hair regeneration therapy to market in Asian countries. Since then, it was known that Shiseido would be implementing its own clinical trials of RCH-01 in Japan which would bring RCH-01 to market much sooner than the US clinical trial timelime. Many had thought that Shiseido’s trial would commence in 1st half 2016, but that was not the case. It appears that Shisiedo is finally ready to begin its trial in Japan which would be the only trial necessary to bring the therapy to market, as long as the therapy showed efficacy/safety initially and maintained safety after the duration of the trial. Read More

New Brotzu Interview, Donor Regeneration Technology: Weekly Thoughts 6/24/16

Hello everyone and welcome to another edition of Weekly Thoughts.

We’re now past the halfway point of the year, and quite frankly, I think a lot of people expected there to be more news regarding pivotal clinical trails for some of our favorite hair growth technologies. Nonetheless, the good news continues to pour in and I have a feeling there will be some more major announcements soon. Let’s take a look at some meaningful hair growth treatment news as of recent. Read More

Aclaris Presentation, New Topical for Hair/Color Restore: Weekly Thoughts 6/9/16

Hello Everyone,

Welcome to another edition of Weekly Thoughts. This edition features a presentation update on the JAK inhibitor therapies for hair growth and the announcement of a new startup/treatment for hair growth that is also claimed to restore hair pigment. Wowzas. Let’s take a look. Read More

BiologicsMD: Company on the Rise


Last summer I was happy to discover BiologicsMD, a new biotech startup coming out of Fayetteville, Arkansas. At that time, the company had just announced a new patent for the uses of bone growth, hair growth, and prevention of hair loss. You might imagine it was the latter two that caught my eye. It’s been almost a year since I spoke to BiologicsMD CEO David Owens and featured an article on his company’s hair patent. I thought now would be a good time to check in and see how things were going in The Land of Opportunity.

BMD

A depiction of BMD-1141 activating the Anagen phase.

Read More